Condition
Lung Cancer Non-Small Cell Cancer (NSCLC) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Lung Cancer Non-Small Cell Cancer (NSCLC) clinical trials that are recruiting, at sites in 4 countries (most in Denmark (1), United States (1), China (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Lung Cancer Non-Small Cell Cancer (NSCLC) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| EGFR-TKIs plus PD-1 antibody in first-line EGFR-mutant NSCLC | Phase 2 | Guangzhou, Guangdong | Recruiting | Jun 9, 2026 |
| Ivonescimab alone or with carboplatin/pemetrexed for advanced NSCLC with actionable alterations | Phase 2 | Boston, Massachusetts and 2 other locations | Recruiting | Feb 12, 2026 |
| Combination of immunotherapy and surgery for advanced lung cancer | Phase 2 | Freiburg im Breisgau, Baden-Wurttemberg and 4 other locations | Recruiting | Feb 5, 2025 |
| Rehabilitation program for lung cancer patients | — | Herlev, Denmark | Recruiting | Nov 26, 2024 |
All recruiting trials (4)
-
EGFR-TKIs plus PD-1 antibody in first-line EGFR-mutant NSCLC
This study tests whether adding a PD-1 antibody to a first-line EGFR-TKI helps people with EGFR-mutant advanced NSCLC see longer progression-free survival.
-
Ivonescimab alone or with carboplatin/pemetrexed for advanced NSCLC with actionable alterations
This trial tests if ivonescimab, alone or with chemotherapy, can shrink tumors in advanced NSCLC patients who have actionable genomic alterations after prior targeted therapies.
-
Combination of immunotherapy and surgery for advanced lung cancer
This study is testing if a new combination of immunotherapy and surgery can help people with advanced lung cancer live longer and healthier compared to current treatments.
-
Rehabilitation program for lung cancer patients
This study is testing a new way to help lung cancer patients get involved in rehabilitation programs earlier to see if it improves their physical abilities and quality of life.
Related topics
Quick answers
How many Lung Cancer Non-Small Cell Cancer (NSCLC) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Denmark (1 trial), United States (1 trial), China (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.